New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study Suggests Role for CAR Therapy After Transplant in Advanced B-cell Cancers

Study Suggests Role for CAR Therapy After Transplant in Advanced B-cell Cancers

December 5, 2015Anita T. ShafferGene therapy has the potential to deliver long-lasting remissions for patients with advanced B-cell malignancies who already have undergone an allogeneic hematopoietic
World medicine November 21,2023
Study Suggests Role for CAR Therapy After Transplant in Advanced B-cell Cancers

Study Suggests Role for CAR Therapy After Transplant in Advanced B-cell Cancers

December 5, 2015Anita T. ShafferGene therapy has the potential to deliver long-lasting remissions for patients with advanced B-cell malignancies who already have undergone an allogeneic hematopoietic
World medicine November 21,2023
Serum Biomarkers Are Early Predictors for Haplo-SCT Outcomes

Serum Biomarkers Are Early Predictors for Haplo-SCT Outcomes

June 12, 2020Jason HarrisHigher levels of the serum biomarkers ST2 and REG3α were associated with increased incidence of graft-vs-host disease and increased risk for transplant-related mortality in pa
World medicine November 21,2023
Serum Biomarkers Are Early Predictors for Haplo-SCT Outcomes

Serum Biomarkers Are Early Predictors for Haplo-SCT Outcomes

June 12, 2020Jason HarrisHigher levels of the serum biomarkers ST2 and REG3α were associated with increased incidence of graft-vs-host disease and increased risk for transplant-related mortality in pa
World medicine November 21,2023
Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

May 3, 2018Jason HarrisEliminating T cells carrying alpha and beta chains of the T-cell receptor reduced the risk for graft-versus-host-disease while producing "excellent" engraftment kineti
World medicine November 21,2023
Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

Selective T-Cell Depletion Improves Engraftment, Reduces GVHD in Pediatric/AYA Leukemia

May 3, 2018Jason HarrisEliminating T cells carrying alpha and beta chains of the T-cell receptor reduced the risk for graft-versus-host-disease while producing "excellent" engraftment kineti
World medicine November 21,2023
Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

April 17, 2017Ariela KatzThe international CanStem303C trial is evaluating the combination of napabucasin, the most advanced cancer stemness inhibitor in development, with FOLFIRI chemotherapy in pati
World medicine November 21,2023
Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

April 17, 2017Ariela KatzThe international CanStem303C trial is evaluating the combination of napabucasin, the most advanced cancer stemness inhibitor in development, with FOLFIRI chemotherapy in pati
World medicine November 21,2023
Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

June 14, 2016Vaishalee Kenkre, MD, Walter Longo, MDPeiman Hematti, MDThis pilot trial is the first of its type to investigate T cell receptor alpha/beta-depleted and CD19-depleted haploidentical stem
World medicine November 21,2023
Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

June 14, 2016Vaishalee Kenkre, MD, Walter Longo, MDPeiman Hematti, MDThis pilot trial is the first of its type to investigate T cell receptor alpha/beta-depleted and CD19-depleted haploidentical stem
World medicine November 21,2023
No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

August 7, 2015Colleen S. Delaney, MD, MSCThe perception that cord blood is an inferior source of stem cells is simply not accurate and may result in delays in lifesaving treatment for patients.Colleen
World medicine November 21,2023
No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

August 7, 2015Colleen S. Delaney, MD, MSCThe perception that cord blood is an inferior source of stem cells is simply not accurate and may result in delays in lifesaving treatment for patients.Colleen
World medicine November 21,2023
Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

December 11, 2011Ben LeachStudy finds that peripheral blood stem cell (PBSC) transplants increase the incidence of graft-versus-host disease (GVHD).A new study has found that peripheral blood stem cel
World medicine November 21,2023
Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

December 11, 2011Ben LeachStudy finds that peripheral blood stem cell (PBSC) transplants increase the incidence of graft-versus-host disease (GVHD).A new study has found that peripheral blood stem cel
World medicine November 21,2023
Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

November 15, 2011Bonnie GillisWilliam I. Bensinger, MD, tackles the complex subject of the role of hematopoietic stem cell transplantation (HSCT), including when to transplant and whether to use allog
World medicine November 21,2023
Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

November 15, 2011Bonnie GillisWilliam I. Bensinger, MD, tackles the complex subject of the role of hematopoietic stem cell transplantation (HSCT), including when to transplant and whether to use allog
World medicine November 21,2023
First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

February 11, 2016Greg KenneltyKelly JohnsonManish A. Shah, MD, discusses the BRIGHTER trial, which is investigated BBI608 as a second-line treatment for patients with gastric and gastroesophageal junc
World medicine November 21,2023
First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

February 11, 2016Greg KenneltyKelly JohnsonManish A. Shah, MD, discusses the BRIGHTER trial, which is investigated BBI608 as a second-line treatment for patients with gastric and gastroesophageal junc
World medicine November 21,2023
Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

June 21, 2018Gina ColumbusMax Wicha, MD, shares insight on the intriguing research being conducted on breast cancer stem cells.Max Wicha, MD, associate professor of oncology and urology at Johns Hopki
World medicine November 21,2023
Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

June 21, 2018Gina ColumbusMax Wicha, MD, shares insight on the intriguing research being conducted on breast cancer stem cells.Max Wicha, MD, associate professor of oncology and urology at Johns Hopki
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com